Skip to main content
. 2019 Jun 17;2019:8302950. doi: 10.1155/2019/8302950

Figure 8.

Figure 8

Diagram illustrating a model for how FSS might attenuate Alzheimer's disease-related pathologies via the gut-liver-brain axis in APP/PS1 AD mice. FSS might operate via the gut-liver-brain axis to regulate AP activity and gut bacterial populations, attenuate Aβ, LPS-related systemic inflammation, and oxidative stress (MDA), thereby alleviating AD-related pathologies in APP/PS1 AD mice. We hypothesize that FSS might improve the gastrointestinal (GI) barrier and blood-brain barrier, thereby ameliorating AD-related pathologies. Aβ: amyloid-β; AP: alkaline phosphatase; LPS: lipopolysaccharides; MDA: malondialdehyde, lipid peroxidation products; AD: Alzheimer's disease.